ACAD
ACADIA PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$21.18
+2.94%Forward multiples
Based on analyst estimates
- P/E forward
- 22.69x
- P/E 2026E
- 33.66x
- P/E 2027E
- 22.36x
- P/E 2028E
- 13.24x
- P/S forward
- 2.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- 9.41x
- PEG TTM
- —
- Price / book
- 2.79x
- Price / sales
- 3.20x
- Price / cash flow
- 18.78x
Enterprise value
- Enterprise value
- $2.8B
- EV / sales
- 2.43x
- EV / EBITDA
- 23.82x
- EV / EBIT
- 32.03x
- Market cap
- $3.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026